RXO, Inc.
NYSE:RXOTrucking
+$0.80 today
- Market cap
- $4.72B
- Beta
- 1.97
- P/E (TTM)
- -41.3
- EPS (TTM)
- -$0.62
Volume 3.64M
Average 2.33M
RXO Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
RXO, Inc.NYSE: RXO
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 99.9% from a year ago
Cash & equivalents stood at $15K at the end of Q2 FY2026, down 99.9% from a year earlier and down 99.9% from the prior quarter. Over 3 fiscal years it compounded at -43.2% a year.
Context
- Cash & equivalents amounted to 0.4% of total assets at the end of Q2 FY2026, down 0.1 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -99.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 18M USD
- Year-over-year change
- -48.6%
- 4-year CAGR
- -11.2%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18M | -48.6% |
| FY2024 | 2024-12-31 | 35M | +600.0% |
| FY2023 | 2023-12-31 | 5M | -94.9% |
| FY2022 | 2022-12-31 | 98M | +237.9% |
| FY2021 | 2021-12-31 | 29M | — |
Cash & Equivalents vs competitors
How RXO compares with its peers on the latest reported figures
- RXO's Jun 2026 cash & equivalents of $15K is the lowest of the 11 companies compared; the peer median is $228.25M.
- Its year-over-year change of -99.9% is the lowest of 11, against a peer median of +49.4%.
- Cash & equivalents amounts to 0.4% of total assets for RXO, versus a peer median of 8.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $692.48M | +39.4% | +15.4% | 14.2% | |
| Sep 2026 | $463.81M | -25.4% | +182.8% | 20.7% | |
TICTIC Solutions, Inc. | Jun 2026 | $362.42M | +178.7% | — | 8.4% |
| Jun 2026 | $352.58M | +12.3% | -11.9% | 8.9% | |
| Jun 2026 | $337.2M | +11.7% | +78.2% | 7.5% | |
| Jun 2026 | $119.3M | +101.9% | -17.6% | 2.5% | |
| Jul 2026 | $110.5M | +59.5% | +12.6% | 2.0% | |
| Mar 2026 | $90.72M | +303.5% | +34.9% | 10.2% | |
| Mar 2026 | $62.35M | +28.8% | +9.1% | 47.7% | |
| Jun 2026 | $4.38M | +198.1% | -32.4% | 0.2% | |
| Jun 2026 | $15K | -99.9% | -43.2% | 0.4% | |
| Peer median (excluding RXO) | $228.25M | +49.4% | +12.6% | 8.7% | |
Competitors are the stored peer set for RXO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
RXO, Inc.
NYSE:RXO
Intrinsic Alpha fair value
Locked
Current Price
$28.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.